CPSE:OSSR

Stock Analysis Report

Executive Summary

Össur hf., together with its subsidiaries, develops, produces, and sells non-invasive orthopedic products in Europe, the Middle-East, Africa, the Americas, and the Asia-Pacific.

Snowflake

Fundamentals

Acceptable track record with mediocre balance sheet.


Similar Companies

Share Price & News

How has Össur hf's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

1.9%

OSSR

0.9%

DK Medical Equipment

0.5%

DK Market


1 Year Return

37.9%

OSSR

6.2%

DK Medical Equipment

10.7%

DK Market

Return vs Industry: OSSR exceeded the Danish Medical Equipment industry which returned 6.2% over the past year.

Return vs Market: OSSR exceeded the Danish Market which returned 10.7% over the past year.


Shareholder returns

OSSRIndustryMarket
7 Day1.9%0.9%0.5%
30 Day-11.0%-4.7%-1.2%
90 Day8.8%-3.8%0.9%
1 Year38.5%37.9%7.7%6.2%14.1%10.7%
3 Year80.7%78.2%65.7%57.6%32.9%21.7%
5 Year178.4%171.8%107.5%89.5%67.9%43.9%

Price Volatility Vs. Market

How volatile is Össur hf's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Össur hf undervalued compared to its fair value and its price relative to the market?

33.56x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Undervalued: OSSR (DKK46.2) is trading above our estimate of fair value (DKK35.99)

Significantly Undervalued: OSSR is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: OSSR is poor value based on its PE Ratio (33.6x) compared to the Medical Equipment industry average (33.6x).

PE vs Market: OSSR is poor value based on its PE Ratio (33.6x) compared to the Danish market (14.7x).


Price to Earnings Growth Ratio

Low PEG Ratio: OSSR is poor value based on its PEG Ratio (2.7x)


Price to Book Ratio

PB vs Industry: OSSR is good value based on its PB Ratio (5.3x) compared to the DK Medical Equipment industry average (6.7x).


Next Steps

Future Growth

How is Össur hf forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

12.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: OSSR's forecast earnings growth (12.4% per year) is above the savings rate (0.2%).

Earnings vs Market: OSSR's earnings (12.4% per year) are forecast to grow faster than the Danish market (12.1% per year).

High Growth Earnings: OSSR's earnings are forecast to grow, but not significantly.

Revenue vs Market: OSSR's revenue (7.1% per year) is forecast to grow slower than the Danish market (6.8% per year).

High Growth Revenue: OSSR's revenue (7.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: OSSR's Return on Equity is forecast to be low in 3 years time (14.3%).


Next Steps

Past Performance

How has Össur hf performed over the past 5 years?

7.6%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: OSSR's earnings have grown by 7.6% per year over the past 5 years.

Accelerating Growth: OSSR's earnings growth over the past year (32.5%) exceeds its 5-year average (7.6% per year).

Earnings vs Industry: OSSR earnings growth over the past year (32.5%) exceeded the Medical Equipment industry 13.1%.


Return on Equity

High ROE: OSSR's Return on Equity (15.7%) is considered low.


Return on Assets

ROA vs Industry: OSSR's Return on Assets is below or equal to the Medical Equipment industry average last year.


Return on Capital Employed

ROCE Improving: OSSR's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is Össur hf's financial position?


Financial Position Analysis

Short Term Liabilities: OSSR's short term assets ($278.1M) exceeds its short term liabilities ($131.3M)

Long Term Liabilities: OSSR's short term assets (278.1M) do not cover its long term liabilities (337.7M)


Debt to Equity History and Analysis

Debt Level: OSSR's debt to equity ratio (40.8%) is considered high

Reducing Debt: OSSR's debt to equity ratio has increased from 30.1% to 40.8% over the past 5 years.

Debt Coverage: OSSR's debt is well covered by operating cash flow (37.4%).

Interest Coverage: OSSR's interest payments on its debt are well covered by EBIT (17.6x coverage).


Balance Sheet

Inventory Level: OSSR has a high level of physical assets or inventory.

Debt Coverage by Assets: OSSR's debt is covered by short term assets (assets are 1.233140x debt).


Next Steps

Dividend

What is Össur hf's current dividend yield, its reliability and sustainability?

0.30%

Current Dividend Yield


Dividend Yield vs Market

company0.3%marketbottom25%1.7%markettop25%5.1%industryaverage1.4%forecastin3Years0.4%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: OSSR's dividend (0.3%) isn’t notable compared to the bottom 25% of dividend payers in the Danish market (1.74%).

High Dividend: OSSR's dividend (0.3%) is low compared to the top 25% of dividend payers in the Danish market (5.05%).

Stable Dividend: OSSR is not paying a notable dividend for the Danish market, therefore no need to check if payments are stable.

Growing Dividend: OSSR is not paying a notable dividend for the Danish market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: OSSR is not paying a notable dividend for the Danish market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of OSSR's dividend in 3 years as they are not forecast to pay a notable one for the Danish market.


Next Steps

Management

What is the CEO of Össur hf's salary, the management and board of directors tenure and is there insider trading?

5.0yrs

Average management tenure


CEO

Jón Sigurdsson (63yo)

23.8yrs

Tenure

US$2,062,000

Compensation

Mr. Jón Sigurdsson has been the Chief Executive Officer and President of Gibaud SAS since 1996. Mr. Sigurdsson has been Senior Vice President of Procurement at Promens Canada Inc. and Promens hf. since Jul ...


CEO Compensation Analysis

Compensation vs. Market: Jón's total compensation ($USD2.06M) is about average for companies of similar size in the Danish market ($USD2.03M).

Compensation vs Earnings: Jón's compensation has been consistent with company performance over the past year.


Management Age and Tenure

5.0yrs

Average Tenure

50yo

Average Age

Experienced Management: OSSR's management team is seasoned and experienced (5 years average tenure).


Board Age and Tenure

10.8yrs

Average Tenure

62yo

Average Age

Experienced Board: OSSR's board of directors are seasoned and experienced ( 10.8 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Jón Sigurdsson (63yo)

    CEO & President

    • Tenure: 23.8yrs
    • Compensation: US$2.06m
  • Ossur Kristinsson (76yo)

    • Tenure: 0yrs
    • Compensation: US$25.00k
  • Egill Jónsson (62yo)

    Executive Vice President of Manufacturing & Operations

    • Tenure: 0yrs
    • Compensation: US$444.00k
  • Ólafur Gylfason (50yo)

    Executive Vice President of Sales & Marketing

    • Tenure: 3.7yrs
    • Compensation: US$600.00k
  • Sigurborg Arnarsdottir

    Compliance Officer

    • Tenure: 17.8yrs
  • Sveinn Sölvason (41yo)

    Chief Financial Officer

    • Tenure: 6.4yrs
    • Compensation: US$221.00k
  • Margrét Friðriksdóttir (41yo)

    Executive Vice President of Human Resources & Corporate Strategy

    • Tenure: 0yrs
    • Compensation: US$242.00k
  • Kim de Roy (42yo)

    Executive Vice President of Research & Development

    • Tenure: 1.9yrs
  • Gudjon Karason (50yo)

    Executive Vice President of Clinics

    • Tenure: 1.9yrs
  • David Hreidarsson

    Investor Relations Manager

    • Tenure: 0yrs

Board Members

  • Niels Jacobsen (62yo)

    Chairman of the Board

    • Tenure: 13.8yrs
    • Compensation: US$94.00k
  • Kristján Ragnarsson (76yo)

    Vice Chairman

    • Tenure: 7.6yrs
    • Compensation: US$56.00k
  • Svafa Grönfeldt (54yo)

    Director

    • Tenure: 11.8yrs
    • Compensation: US$38.00k
  • Guðbjörg Eggertsdóttir (68yo)

    Director

    • Tenure: 6.6yrs
    • Compensation: US$38.00k
  • Arne Nielsen (51yo)

    Director

    • Tenure: 10.8yrs
    • Compensation: US$38.00k

Company Information

Össur hf.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Össur hf.
  • Ticker: OSSR
  • Exchange: CPSE
  • Founded: 1971
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: ø19.534b
  • Shares outstanding: 422.82m
  • Website: https://www.ossur.com

Number of Employees


Location

  • Össur hf.
  • Grjothals 1 - 5
  • Reykjavik
  • 110
  • Iceland

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
0FIWLSE (London Stock Exchange)YesCommon StockGBDKKOct 1999
OSSRCPSE (OMX Nordic Exchange Copenhagen)YesCommon StockDKDKKOct 1999
OSSRCBATS-CHIXE (BATS 'Chi-X Europe')YesCommon StockGBDKKOct 1999
OSSF.FOTCPK (Pink Sheets LLC)YesCommon StockUSUSDOct 1999
OSSU.YOTCPK (Pink Sheets LLC)SPONSORED ADRUSUSDDec 2011

Biography

Össur hf., together with its subsidiaries, develops, produces, and sells non-invasive orthopedic products in Europe, the Middle-East, Africa, the Americas, and the Asia-Pacific. The company’s prosthetics p ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/18 21:13
End of Day Share Price2019/10/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.